Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -275,958 | -111,704 | -36,160 | -653,251 | -482,923 |
| Depreciation Amortization | 4,708 | 3,170 | 1,596 | 15,401 | 4,909 |
| Accounts receivable | N/A | 1,091 | -233,743 | 15,328 | N/A |
| Accounts payable and accrued liabilities | 5,257 | 8,858 | -5,927 | 2,780 | -3,404 |
| Other Working Capital | 19,097 | 21,239 | -225,199 | 5,057 | -16,922 |
| Other Operating Activity | -78,504 | -67,488 | 279,896 | 86,965 | 95,439 |
| Operating Cash Flow | $-325,400 | $-144,834 | $-219,537 | $-527,720 | $-402,901 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -886 | -749 | -695 | -1,306 | -871 |
| Purchase Of Investment | -114,082 | -114,082 | -64,666 | -137,264 | -108,040 |
| Sale Of Investment | 158,229 | 118,229 | 63,229 | 193,106 | 163,513 |
| Purchase Sale Intangibles | -4,785 | -3,190 | -797 | N/A | N/A |
| Other Investing Activity | 20,757 | 22,394 | 24,885 | -503 | -503 |
| Investing Cash Flow | $64,018 | $25,792 | $22,753 | $54,033 | $54,099 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 450,000 | 450,000 | 450,000 | N/A | N/A |
| Debt Repayment | -473,417 | -473,417 | -473,417 | N/A | N/A |
| Common Stock Issued | 320,051 | 317,901 | 318,155 | 459,216 | 458,883 |
| Common Stock Repurchased | -6,122 | -4,679 | -2,936 | -6,880 | -4,325 |
| Other Financing Activity | -15,986 | -15,986 | -12,254 | -801 | 1,500 |
| Financing Cash Flow | $274,526 | $273,819 | $279,548 | $451,535 | $456,058 |
| Beginning Cash Position | 394,732 | 394,732 | 394,732 | 416,884 | 416,884 |
| End Cash Position | 407,876 | 549,509 | 477,496 | 394,732 | 524,140 |
| Net Cash Flow | $13,144 | $154,777 | $82,764 | $-22,152 | $107,256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -325,400 | -144,834 | -219,537 | -527,720 | -402,901 |
| Capital Expenditure | -886 | -749 | -695 | -1,306 | -871 |
| Free Cash Flow | -326,286 | -145,583 | -220,232 | -529,026 | -403,772 |